Dr Christina Yap is a Reader in Biostatistics and Clinical Trials and the Principal Biostatistician at Cancer Research UK Clinical Trials Unit (CRCTU), within the Institute of Cancer and Genomic Sciences at the University of Birmingham. She has over 11 years of experience in statistical design and analysis of clinical trials (with 9 years of specialist experience in early phase trials). Her main expertise comprises of developing efficient trial designs and practical implementation of such designs in clinical trials. This includes adaptive designs in early phase dose-finding trials as well as multi-stage randomised Phase II/III designs; including Bayesian approaches to such settings.
She is a selected member of three National Cancer Research Institute (NCRI) Clinical Studies Group: Head and Neck Cancer Cancer, Skin Cancer and NCRI Clinical and Translational Radiotherapy Research Working Group (CTRad). She is the statistical lead for trials in various disease areas, which include head and neck cancer, skin cancer, leukaemia and liver diseases within the trials unit in Birmingham.